INVA: Innoviva, Inc.
Performance
INVA -8.92%
Watchlist
Select an item
Summary
INVA at a glance
INVA returned -8.92% over the past year and +0.95% a year over five years. Its worst drop in that year was -21.62%, smaller than 76% of stocks on Redstone, and its Sharpe ratio of -0.38 beats 14% of stocks on Redstone. It pays no dividends.
Current Drawdown
-21.62%
Rolling Volatility
37.81%
Actions
Metrics
Risk Indicators
Alpha-12.90%
Beta0.32x
Sharpe-0.38
Sortino-0.51
Omega0.94
Calmar-0.41
Martin-0.98
Profile
About INVA
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.4B
- Listed
- Oct 2004
- Employees
- 159
- Headquarters
- Burlingame, CA
- Website
- inva.com
Comparisons